Department of Maternal-Fetal Medicine, Geisinger Health System, 100 N Academy Avenue, Danville, PA 17822, USA.
Research Department, American College of Obstetricians and Gynecologists, 409 12th Street SW, Washington, DC 20024, USA.
Vaccine. 2018 Jul 16;36(30):4548-4554. doi: 10.1016/j.vaccine.2018.05.121. Epub 2018 Jun 12.
Routine influenza and tetanus, diphtheria and acellular pertussis (Tdap) vaccination of pregnant women to prevent poor maternal, fetal and neonatal outcomes is recommended practice; however, actual rates of influenza vaccine acceptance are typically well below the (Healthy People 2020, 2015) goal of 80%.
We sought to identify barriers to accepting either vaccination.
From December 2014 to April 2015 women were given a questionnaire eliciting their experiences, attitudes and history of influenza and Tdap vaccination in pregnancy during their routine prenatal care appointments at a tertiary care center. Patient demographics were included in the questionnaire. A similar questionnaire was administered to prenatal care providers. Patient influenza and Tdap vaccination acceptance rates were compared and predictors of vaccine acceptance were analyzed with bivariate logistic regression.
Out of the 400 patient questionnaires distributed, 338 (84.5%) were completed and returned; 24 of 45 (53.3%) provider questionnaires were returned. Vaccination acceptance rates were 70.7% for the influenza vaccine and 76.3% for the Tdap vaccine. The logistic regression model indicated that predictors of acceptance for either vaccine in pregnancy are patient attitude and previous vaccination history. Patient attitudes were more favorable towards Tdap than influenza vaccination. The combination of healthcare provider recommendation and educational materials was significantly predictive of both Tdap and influenza vaccine acceptance. The most common reasons given for declining the influenza vaccine were safety concerns; the most common reasons given for declining the Tdap vaccine were that patients did not think it was required again when they received the vaccine before pregnancy.
Our study suggests that providers can improve Tdap and influenza vaccination acceptance in pregnancy by recommending the vaccination in combination with provision of educational materials on the vaccines.
建议孕妇常规接种流感和破伤风、白喉及无细胞百日咳(Tdap)疫苗,以预防母婴、胎儿和新生儿不良结局;然而,实际的流感疫苗接种率通常远低于(健康人 2020 年,2015 年)80%的目标。
我们旨在确定接受这两种疫苗接种的障碍。
2014 年 12 月至 2015 年 4 月,在一家三级保健中心的常规产前护理就诊期间,向孕妇发放问卷,了解她们在妊娠期间接种流感和 Tdap 疫苗的经历、态度和既往史。问卷中包括患者人口统计学资料。同时也向产前护理提供者发放了一份类似的问卷。比较了患者流感和 Tdap 疫苗接种接受率,并通过二变量逻辑回归分析了疫苗接种接受的预测因素。
在发放的 400 份患者问卷中,有 338 份(84.5%)完成并返回;45 份提供者问卷中,有 24 份(53.3%)返回。流感疫苗的接种接受率为 70.7%,Tdap 疫苗的接种接受率为 76.3%。逻辑回归模型表明,妊娠期间接种任何一种疫苗的预测因素是患者态度和既往接种史。患者对 Tdap 的态度比对流感疫苗更有利。医疗服务提供者的建议和教育材料的组合对 Tdap 和流感疫苗的接种接受都具有显著的预测作用。拒绝接种流感疫苗的最常见原因是安全性问题;拒绝接种 Tdap 疫苗的最常见原因是患者认为在怀孕前已经接种过疫苗,不需要再次接种。
我们的研究表明,提供者可以通过联合推荐疫苗接种并提供疫苗相关教育材料,提高妊娠期间 Tdap 和流感疫苗的接种接受率。